Literature DB >> 14748803

Human fusariosis.

M C Dignani1, E Anaissie.   

Abstract

Fusarium species frequently implicated in human infections include F. solani, F. oxysporum and F. moniliforme. Among immunocompetent patients, tissue breakdown (as caused by trauma, severe burns or foreign body) is the risk factor for fusariosis. Infections include keratitis, onychomycosis and occasionally peritonitis and cellulitis. Treatment is usually successful and requires removal of the foreign body as well as antifungal therapy. Among immunocompromised patients, mainly patients with haematological malignancies, Fusarium spp. are the second most common pathogenic mould. Risk factors for disseminated fusariosis include severe immunosuppression (neutropenia, lymphopenia, graft-versus-host disease, corticosteroids), colonisation, tissue damage, and receipt of a graft from an HLA-mismatched or unrelated donor. Clinical presentation includes refractory fever (> 90%), skin lesions and sino-pulmonary infections ( approximately 75%). Type of skin lesions includes ecthyma-like, target, and multiple subcutaneous nodules. Skin lesions lead to diagnosis in > 50% of patients and precede fungemia by approximately 5 days. In contrast to disseminated aspergillosis, disseminated fusariosis can be diagnosed by blood cultures in 40% of patients. Histopathology reveals hyaline acute-branching septate hyphae similar to those found in aspergillosis. Mortality from fusarial infections in immunocompromised patients ranges from 50% to 80%. Host immune status is the single most important factor predicting outcome. Persistent neutropenia and corticosteroid therapy significantly affect survival. Optimal treatment has not been established. Anecdotal successes have been reported with various agents (high-dose amphotericin B, lipid-based amphotericin B formulations, itraconazole, voriconazole) and with cytokine-stimulated granulocyte transfusions. Preventing fusariosis relies on detection and treatment of cutaneous damage prior to commencing immunosuppression and decreasing environmental exposure to Fusaria (via air and water).

Entities:  

Mesh:

Year:  2004        PMID: 14748803     DOI: 10.1111/j.1470-9465.2004.00845.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  67 in total

1.  Internet-accessible DNA sequence database for identifying fusaria from human and animal infections.

Authors:  Kerry O'Donnell; Deanna A Sutton; Michael G Rinaldi; Brice A J Sarver; S Arunmozhi Balajee; Hans-Josef Schroers; Richard C Summerbell; Vincent A R G Robert; Pedro W Crous; Ning Zhang; Takayuki Aoki; Kyongyong Jung; Jongsun Park; Yong-Hwan Lee; Seogchan Kang; Bongsoo Park; David M Geiser
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

2.  A case of primary localized cutaneous infection due to Fusarium oxysporum.

Authors:  C Romano; P Caposciutti; A Ghilardi; C Miracco; M Fimiani
Journal:  Mycopathologia       Date:  2010-02-24       Impact factor: 2.574

3.  Fusarium verticillioides abscess of the nasal septum in an immunosuppressed child: case report and identification of the morphologically atypical fungal strain.

Authors:  Hans Jürgen Dornbusch; Walter Buzina; Richard C Summerbell; Cornelia Lass-Flörl; Herwig Lackner; Wolfgang Schwinger; Petra Sovinz; Christian Urban
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex.

Authors:  Mónica Azor; Josepa Gené; Josep Cano; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

5.  Target lesions in a neutropenic patient.

Authors:  Zaw Min; Peter G Pappas
Journal:  Intern Emerg Med       Date:  2013-11-30       Impact factor: 3.397

Review 6.  [Differential diagnosis for detection of hyphae in tissue].

Authors:  K Tintelnot
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

Review 7.  Distribution of Keratinophilic Fungi in Soil Across Tunisia: A Descriptive Study and Review of the Literature.

Authors:  Sonia Anane; Mohammed Hashim Yasir Al-Yasiri; Anne-Cécile Normand; Stéphane Ranque
Journal:  Mycopathologia       Date:  2015-02-18       Impact factor: 2.574

8.  International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

Authors:  Olivier Lortholary; Gaelle Obenga; Pinaki Biswas; Denis Caillot; Elisabeth Chachaty; Anne-Lise Bienvenu; Muriel Cornet; John Greene; Raoul Herbrecht; Claire Lacroix; Frédéric Grenouillet; Issam Raad; Karine Sitbon; Peter Troke
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

9.  Fungaemia caused by Fusarium proliferatum in a patient without definite immunodeficiency.

Authors:  Cédric Dananché; Pierre Cassier; Marc Sautour; Nadine Gautheron; Julien Wegrzyn; Michel Perraud; Anne-Lise Bienvenu; Marie-Christine Nicolle; André Boibieux; Philippe Vanhems
Journal:  Mycopathologia       Date:  2014-09-25       Impact factor: 2.574

Review 10.  Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature.

Authors:  Greg P Bourgeois; Jennifer A Cafardi; Klaus Sellheyer; Aleodor A Andea
Journal:  Cutis       Date:  2010-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.